title: Management of diabetic neuropathy.
abstract: Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10% of diabetic patients after 5 years and in 15% after 20 years. Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.
authors: Senior Consultant Neurologist, Department of Medicine, Medical Faculty UKM.
authors: Raymond Azman
authors: RA
authors: Ali
keywords: Diabetes Mellitus; Management; Neuropathy
references: Neurology. 1998 Sep;51(3):695-702
references: 9748012
references: Diabetes. 1997 Sep;46 Suppl 2:S90-3
references: 9285506
references: JAMA. 1997 Apr 2;277(13):1046-51
references: 9091692
references: J Neuropathol Exp Neurol. 1996 Dec;55(12):1181-93
references: 8957441
references: Diabetes. 1997 Sep;46 Suppl 2:S54-7
references: 9285500
references: Arch Neurol. 1995 Nov;52(11):1053-61
references: 7487556
references: Philos Trans R Soc Lond B Biol Sci. 1996 Mar 29;351(1338):449-54
references: 8730784
references: Ann Intern Med. 1995 Apr 15;122(8):561-8
references: 7887548
references: J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):310-8
references: 9120441
references: Neurology. 1997 May;48(5):1212-8
references: 9153445
references: Diabetes. 1997 Sep;46 Suppl 2:S62-6
references: 9285502